ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.780
+0.010 (0.27%)
At close: Apr 29, 2026, 4:00 PM EDT
3.750
-0.030 (-0.79%)
After-hours: Apr 29, 2026, 4:58 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $480.78 million as of April 29, 2026. Its market cap has increased by 297.72% in one year.
Market Cap
480.78M
Enterprise Value
659.62M
1-Year Change
297.72%
Ranking
Category
Stock Price
$3.78
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $480.78M, a decrease of -76.46%. That is a compound annual growth rate of -21.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 522.79M |
| Eikon Therapeutics | 522.71M |
| Immix Biopharma | 522.17M |
| Fulcrum Therapeutics | 522.15M |
| Verastem | 519.15M |
| Zura Bio | 510.46M |
| MiMedx Group | 509.58M |
| Upstream Bio | 506.11M |